Ocrelizumab Intravenous and Parathyroid hormone Subcutaneous
Determining the interaction of Ocrelizumab Intravenous and Parathyroid hormone Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ocrelizumab
Brand name: Ocrevus
Synonyms: Ocrelizumab (Intravenous), Ocrelizumab
Generic Name: parathyroid hormone
Brand name: Natpara
Synonyms: Parathyroid hormone, Parathyroid Hormone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ocrelizumab Intravenous-Parcopa
- Ocrelizumab Intravenous-Paregoric
- Ocrelizumab Intravenous-Paremyd
- Ocrelizumab Intravenous-Paremyd Ophthalmic
- Ocrelizumab Intravenous-Paricalcitol
- Ocrelizumab Intravenous-Paricalcitol Capsules
- Parathyroid hormone Subcutaneous-Ocrevus
- Parathyroid hormone Subcutaneous-Octagam
- Parathyroid hormone Subcutaneous-Octagam Gammagard S/D
- Parathyroid hormone Subcutaneous-Octocaine
- Parathyroid hormone Subcutaneous-Octocaine 100
- Parathyroid hormone Subcutaneous-OctreoScan